Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3672880
Max Phase: Preclinical
Molecular Formula: C25H22FN3O7S
Molecular Weight: 527.53
Molecule Type: Small molecule
Associated Items:
ID: ALA3672880
Max Phase: Preclinical
Molecular Formula: C25H22FN3O7S
Molecular Weight: 527.53
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(Cc1ccc(C(=O)Oc2ccc(C(=N)N)cc2F)s1)C(=O)Nc1ccc(C(=O)O)c(C(=O)O)c1
Standard InChI: InChI=1S/C25H22FN3O7S/c1-25(2,24(35)29-13-4-6-15(21(30)31)16(10-13)22(32)33)11-14-5-8-19(37-14)23(34)36-18-7-3-12(20(27)28)9-17(18)26/h3-10H,11H2,1-2H3,(H3,27,28)(H,29,35)(H,30,31)(H,32,33)
Standard InChI Key: PPLWQAMMKNZODE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 527.53 | Molecular Weight (Monoisotopic): 527.1162 | AlogP: 3.99 | #Rotatable Bonds: 9 |
Polar Surface Area: 179.87 | Molecular Species: ZWITTERION | HBA: 7 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 2.88 | CX Basic pKa: 10.94 | CX LogP: 2.99 | CX LogD: 1.10 |
Aromatic Rings: 3 | Heavy Atoms: 37 | QED Weighted: 0.12 | Np Likeness Score: -1.03 |
1. (2015) Heteroarylcarboxylic acid ester derivative, |
2. (2016) Heteroarylcarboxylic acid ester derivative, |
Source(1):